Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus [Erratum]

Abstract

Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus [Erratum] Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus [Erratum]Tavares RCF, Feldner AC, Pinho JR, et al. Infect Drug Resist. 2018;11:1993–2000.Page 1999, reference 40 was listed incorrectly. “Alves da Silva R. Molecular characterization of hepatitis C virus in end-stage renal disease patients under hemodialysis. Journal of Medical Virology 90. 2018;3:537–544.” should read “Alves da Silva R, Todão JS, Kamitani FL, et al. Molecular characterization of hepatitis C virus in end-stage renal disease patients under hemodialysis. Journal of Medical Virology 90. 2018;3:537–544.”Read the original article